ISS Recommends That Aurinia Shareholders Vote "FOR" All Proposals at 2025 Annual General Meeting
Express News | Iss Recommends That Aurinia Shareholders Vote “for” All Proposals at 2025 Annual General Meeting
Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 6.8% Over Last Week
Express News | Mkt Capital and Lucien Selce: Believe Aurinia Shareholders Would Benefit From a Leaner, More Accountable Board
Express News | Concerned Shareholders of Aurinia Pharmaceuticals Announce Their Intention to Withhold Support for CEO Peter Greenleaf at 2025 Annual Meeting
Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March
Aurinia Pharmaceuticals CMO Makes Significant Stock Sale
Signet Jewelers, Big Bear, and More Stocks See Action From Activist Investors -- Barrons.com
Aurinia Pharmaceuticals' (NASDAQ:AUPH) Earnings May Just Be The Starting Point
Aurinia Pharmaceuticals Stock Climbs on Insider Buying
Major Investment Alert: Kevin Tang Boosts Stake in Aurinia Pharmaceuticals
Insider Sale: Chief Financial Officer of $AUPH Sells 56,154 Shares
Aurinia Pharmaceuticals(AUPH.US) Director Buys US$12.71 Million in Common Stock
Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals (AUPH) Stock?
Declining Stock and Decent Financials: Is The Market Wrong About Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)?
Results: Aurinia Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
RBC Capital Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Cuts Target Price to $8
RBC Lowers Price Target on Aurinia Pharmaceuticals to $8 From $9, Keeps Outperform, Speculative Risk
Regulatory and Financial Challenges Loom for Aurinia Pharmaceuticals Despite FDA and EC Approvals
Aurinia Pharmaceuticals Reports Strong 2024 Financial Growth